共 19 条
- [1] THE USE OF DRUGS WHICH DEPLETE INTRACELLULAR GLUTATHIONE IN HYPOXIC CELL RADIOSENSITIZATION [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (3-4): : 439 - 442
- [2] CHABNER BA, 1982, PHARM PRINCIPLES CAN, P276
- [3] PHASE-I CLINICAL-TRIALS OF WR-2721 WITH ALKYLATING AGENT CHEMOTHERAPY [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (3-4): : 575 - 580
- [4] PHASE-I CONTROLLED TRIALS OF WR-2721 AND CYCLOPHOSPHAMIDE [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1984, 10 (09): : 1777 - 1780
- [5] PHASE-I TRIALS OF WR-2721 AND CIS-PLATINUM [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1984, 10 (09): : 1781 - 1784
- [6] GLOVER D, 1985, UNPUB INT J RAD ONCO
- [7] CLINICAL PHARMACOKINETICS OF CYCLOPHOSPHAMIDE [J]. CLINICAL PHARMACOKINETICS, 1979, 4 (05) : 380 - 394
- [9] SURVIVAL CURVES OF IRRADIATED GLUTATHIONE-DEFICIENT HUMAN-FIBROBLASTS - INDICATION OF A REDUCED ENHANCEMENT OF RADIOSENSITIVITY BY OXYGEN AND MISONIDAZOLE [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (3-4): : 443 - 446
- [10] PHILLIPS TL, 1981, SEMIN ONCOL, V8, P65